Stock Events

Stock Events

Rein Therapeutics (RNTX) Q4 2024 Earnings

14NovConfirmed

Q4 2024

-0.27

-0.26

-0.25

-0.25

Details

Expected EPS

-0.245

Actual EPS

-0.27

Surprise EPS

-0.03

Surprise Percent

+10.2%

Description

Rein Therapeutics (RNTX) has reported earnings of -0.27 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.